Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19

One hundred ninety-five patients presenting with post-COVID symptomology, including parosmia and dysgeusia, underwent reversible stellate ganglion blockade. Stellate ganglion blockade was performed at an outpatient facility, and patients were evaluated via survey at seven days post-injection. Of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvin, Vaughna, Cheek, Dennis J, Zhang, Yan, Collins, Gregory, Gaskin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164395/
https://www.ncbi.nlm.nih.gov/pubmed/37162813
http://dx.doi.org/10.2147/LRA.S402197
_version_ 1785038060171296768
author Galvin, Vaughna
Cheek, Dennis J
Zhang, Yan
Collins, Gregory
Gaskin, David
author_facet Galvin, Vaughna
Cheek, Dennis J
Zhang, Yan
Collins, Gregory
Gaskin, David
author_sort Galvin, Vaughna
collection PubMed
description One hundred ninety-five patients presenting with post-COVID symptomology, including parosmia and dysgeusia, underwent reversible stellate ganglion blockade. Stellate ganglion blockade was performed at an outpatient facility, and patients were evaluated via survey at seven days post-injection. Of the 195 participants, ages ranged from 18–69 years of age with the breakdown of sexes being females n = 157 and males n = 38. The most significant finding was a reported improvement in olfaction post-injection in 87.4% of subjects. The effectiveness of this novel treatment for post-COVID is promising and warrants further investigation.
format Online
Article
Text
id pubmed-10164395
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101643952023-05-08 Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19 Galvin, Vaughna Cheek, Dennis J Zhang, Yan Collins, Gregory Gaskin, David Local Reg Anesth Short Report One hundred ninety-five patients presenting with post-COVID symptomology, including parosmia and dysgeusia, underwent reversible stellate ganglion blockade. Stellate ganglion blockade was performed at an outpatient facility, and patients were evaluated via survey at seven days post-injection. Of the 195 participants, ages ranged from 18–69 years of age with the breakdown of sexes being females n = 157 and males n = 38. The most significant finding was a reported improvement in olfaction post-injection in 87.4% of subjects. The effectiveness of this novel treatment for post-COVID is promising and warrants further investigation. Dove 2023-05-03 /pmc/articles/PMC10164395/ /pubmed/37162813 http://dx.doi.org/10.2147/LRA.S402197 Text en © 2023 Galvin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Short Report
Galvin, Vaughna
Cheek, Dennis J
Zhang, Yan
Collins, Gregory
Gaskin, David
Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title_full Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title_fullStr Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title_full_unstemmed Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title_short Short Communication: Stellate Ganglion Blockade for Persistent Olfactory and Gustatory Symptoms Post-COVID-19
title_sort short communication: stellate ganglion blockade for persistent olfactory and gustatory symptoms post-covid-19
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164395/
https://www.ncbi.nlm.nih.gov/pubmed/37162813
http://dx.doi.org/10.2147/LRA.S402197
work_keys_str_mv AT galvinvaughna shortcommunicationstellateganglionblockadeforpersistentolfactoryandgustatorysymptomspostcovid19
AT cheekdennisj shortcommunicationstellateganglionblockadeforpersistentolfactoryandgustatorysymptomspostcovid19
AT zhangyan shortcommunicationstellateganglionblockadeforpersistentolfactoryandgustatorysymptomspostcovid19
AT collinsgregory shortcommunicationstellateganglionblockadeforpersistentolfactoryandgustatorysymptomspostcovid19
AT gaskindavid shortcommunicationstellateganglionblockadeforpersistentolfactoryandgustatorysymptomspostcovid19

Ejemplares similares